Literature DB >> 9228890

Clozapine withdrawal resulting in delirium with psychosis: a report of three cases.

J K Stanilla1, J de Leon, G M Simpson.   

Abstract

BACKGROUND: Withdrawal symptoms for typical antipsychotics are generally mild, self-limited and do not include development of psychotic symptoms. In contrast, withdrawal symptoms for clozapine can be severe with rapid onset of agitation, abnormal movements, and psychotic symptoms. Different pathophysiologic etiologies have been suggested for these severe symptoms, including dopaminergic supersensitivity and rebound.
METHOD: Three case reports of clozapine withdrawal symptoms are presented. A review of previous case reports and discussion of the etiology of withdrawal symptoms of typical antipsychotics and clozapine are provided.
RESULTS: These three patients developed delirium with psychotic symptoms that resolved rapidly and completely upon resumption of low doses of clozapine.
CONCLUSION: The severe agitation and psychotic symptoms after clozapine withdrawal in these three patients were due to delirium, perhaps the result of central cholinergic rebound. The withdrawal symptoms and delirium resolved rapidly with resumption of low doses of clozapine. Severe withdrawal symptoms can probably be avoided by slowly tapering clozapine and/or simultaneously substituting another psychotropic with high anticholinergic activity, such as thioridazine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228890     DOI: 10.4088/jcp.v58n0603

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  16 in total

1.  Effect of anticholinergics in preventing acute deterioration in patients undergoing abrupt clozapine withdrawal.

Authors:  Niko Seppälä; Carita Kovio; Esa Leinonen
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.

Authors:  M Zaudig
Journal:  Drug Saf       Date:  2000-09       Impact factor: 5.606

Review 3.  Effects of Curcumin on Depression and Anxiety: A Narrative Review of the Recent Clinical Data.

Authors:  Mohammad Amin Khodadadegan; Shakiba Azami; Paul C Guest; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part II.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

5.  High-dose Clozapine Withdrawal: A Case Report and Timeline of a Single Potential Withdrawal Seizure.

Authors:  Megan K Skelly; Tammie Lee Demler; Claudia Lee
Journal:  Innov Clin Neurosci       Date:  2019-07-01

Review 6.  Delirium in the elderly. Optimal management.

Authors:  J M Flacker; E R Marcantonio
Journal:  Drugs Aging       Date:  1998-08       Impact factor: 4.271

7.  Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response.

Authors:  Lila Aboueid; Richard H McCarthy
Journal:  Case Rep Psychiatry       Date:  2016-06-28

8.  The Treatment of Clozapine-Withdrawal Delirium with Electroconvulsive Therapy.

Authors:  Anish Modak; Arne Åhlin
Journal:  Case Rep Psychiatry       Date:  2017-11-02

9.  Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia.

Authors:  Minfeng Cheng; Huaying Gu; Liangrong Zheng; Houliang Wang; Zhiyong Zhong; Shenglin Wen
Journal:  Neuropsychiatr Dis Treat       Date:  2016-03-29       Impact factor: 2.570

10.  An Unusual Case of Delirium after Restarting Clozapine.

Authors:  Sourav Khanra; Rati Ranjan Sethy; Sanjay Kumar Munda; Christoday Raja Jayant Khess
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-02-29       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.